Immunogenicity and Safety of a Tetravalent Diphtheria-tetanus-acellular Pertussis-inactivated Poliovirus Vaccine

By Gyhrs Annette   Lyngholm Erik   Larsen Severin Olesen   Aggerbeck Henrik   Heron Iver  

Scandinavian Journal of Infectious Diseases, Vol. 31, Iss. 6, 1999-12 ,pp. : 579-585

Informa Healthcare

Access to resources Recommend Favorite

Primary vaccination of adults with reduced antigen-content diphtheria-tetanus-acellular pertussis or dTpa-inactivated poliovirus vaccines compared to diphtheria-tetanus-toxoid vaccines

By Theeten Heidi   Rümke Hans   Hoppener Floris J. P.   Vilatimó Ramón   Narejos Silvia   Van Damme Pierre   Hoet Bernard  

Current Medical Research and Opinion, Vol. 23, Iss. 11, 2007-11 ,pp. : 2729-2739

Informa Healthcare

Access to resources Recommend Favorite

Communicating Vaccine Safety During the Development and Introduction of Vaccines

By  

Current Drug Safety, Vol. 10, Iss. 1, 2015-03 ,pp. : 55-59

Bentham Science Publishers

Access to resources Recommend Favorite

Safety and immunogenicity of a primary course and booster dose of a combined diphtheria, tetanus, acellular pertussis, hepatitis B and inactivated poliovirus vaccine

By Meriste Sirli   Lutsar Irja   Tamm Eda   Willems Paul  

Scandinavian Journal of Infectious Diseases, Vol. 38, Iss. 5, 2006-05 ,pp. : 350-356

Informa Healthcare

Access to resources Recommend Favorite

Safety of the newer antiepileptic drug oxcarbazepine during pregnancy

By Montouris Georgia  

Current Medical Research and Opinion, Vol. 21, Iss. 5, 2005-05 ,pp. : 693-702

Informa Healthcare

Access to resources Recommend Favorite